# Neuroendocrine Response to Oral Alcohol Administration

> **NCT03165942** · PHASE1 · COMPLETED · sponsor: **Yale University** · enrollment: 64 (actual)

## Conditions studied

- Alcohol Abuse

## Interventions

- **OTHER:** Alcoholic Beverage
- **OTHER:** Non-Alcoholic Beverage
- **DRUG:** Ethanol

## Key facts

- **NCT ID:** NCT03165942
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-08
- **Primary completion:** 2018-06-30
- **Final completion:** 2018-06-30
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2022-08-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03165942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03165942, "Neuroendocrine Response to Oral Alcohol Administration". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03165942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*